Disease model: LAMP-2 enlightens Danon disease

Paul Saftig, Kurt Von Figura, Yoshitaka Tanaka, Renate Lüllmann-Rauch

Research output: Contribution to journalReview article

74 Citations (Scopus)

Abstract

Danon disease ('lysosomal glycogen storage disease with normal acid maltase') is characterized by a cardiomyopathy, myopathy and variable mental retardation. Mutations in the coding sequence of the lysosomal-associated membrane protein 2 (LAMP-2) were shown to cause a LAMP-2 deficiency in patients with Danon disease. LAMP-2 deficient mice manifest a similar vacuolar cardioskeletal myopathy. In addition to the patient reports LAMP-2 deficiency in mice causes pancreatic, hepatocytic, endothelial and leucocyte vacuolation. LAMP-2 deficient mice represent a valuable animal model of Danon disease. They will further be used to study the exact role of LAMP-2 in autophagy and to analyse the consequences of an impaired autophagic pathway in various tissues.

Original languageEnglish
Pages (from-to)37-39
Number of pages3
JournalTrends in Molecular Medicine
Volume7
Issue number1
DOIs
Publication statusPublished - Jan 1 2001

Fingerprint

Lysosomal-Associated Membrane Protein 2
Glycogen Storage Disease Type IIb
Protein Deficiency
Autophagy
Muscular Diseases
Cardiomyopathies
Intellectual Disability
Leukocytes
Animal Models
Mutation

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology

Cite this

Disease model : LAMP-2 enlightens Danon disease. / Saftig, Paul; Von Figura, Kurt; Tanaka, Yoshitaka; Lüllmann-Rauch, Renate.

In: Trends in Molecular Medicine, Vol. 7, No. 1, 01.01.2001, p. 37-39.

Research output: Contribution to journalReview article

Saftig, Paul ; Von Figura, Kurt ; Tanaka, Yoshitaka ; Lüllmann-Rauch, Renate. / Disease model : LAMP-2 enlightens Danon disease. In: Trends in Molecular Medicine. 2001 ; Vol. 7, No. 1. pp. 37-39.
@article{91473ff9792442c59fab4ba944462d4e,
title = "Disease model: LAMP-2 enlightens Danon disease",
abstract = "Danon disease ('lysosomal glycogen storage disease with normal acid maltase') is characterized by a cardiomyopathy, myopathy and variable mental retardation. Mutations in the coding sequence of the lysosomal-associated membrane protein 2 (LAMP-2) were shown to cause a LAMP-2 deficiency in patients with Danon disease. LAMP-2 deficient mice manifest a similar vacuolar cardioskeletal myopathy. In addition to the patient reports LAMP-2 deficiency in mice causes pancreatic, hepatocytic, endothelial and leucocyte vacuolation. LAMP-2 deficient mice represent a valuable animal model of Danon disease. They will further be used to study the exact role of LAMP-2 in autophagy and to analyse the consequences of an impaired autophagic pathway in various tissues.",
author = "Paul Saftig and {Von Figura}, Kurt and Yoshitaka Tanaka and Renate L{\"u}llmann-Rauch",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S1471-4914(00)01868-2",
language = "English",
volume = "7",
pages = "37--39",
journal = "Trends in Molecular Medicine",
issn = "1471-4914",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Disease model

T2 - LAMP-2 enlightens Danon disease

AU - Saftig, Paul

AU - Von Figura, Kurt

AU - Tanaka, Yoshitaka

AU - Lüllmann-Rauch, Renate

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Danon disease ('lysosomal glycogen storage disease with normal acid maltase') is characterized by a cardiomyopathy, myopathy and variable mental retardation. Mutations in the coding sequence of the lysosomal-associated membrane protein 2 (LAMP-2) were shown to cause a LAMP-2 deficiency in patients with Danon disease. LAMP-2 deficient mice manifest a similar vacuolar cardioskeletal myopathy. In addition to the patient reports LAMP-2 deficiency in mice causes pancreatic, hepatocytic, endothelial and leucocyte vacuolation. LAMP-2 deficient mice represent a valuable animal model of Danon disease. They will further be used to study the exact role of LAMP-2 in autophagy and to analyse the consequences of an impaired autophagic pathway in various tissues.

AB - Danon disease ('lysosomal glycogen storage disease with normal acid maltase') is characterized by a cardiomyopathy, myopathy and variable mental retardation. Mutations in the coding sequence of the lysosomal-associated membrane protein 2 (LAMP-2) were shown to cause a LAMP-2 deficiency in patients with Danon disease. LAMP-2 deficient mice manifest a similar vacuolar cardioskeletal myopathy. In addition to the patient reports LAMP-2 deficiency in mice causes pancreatic, hepatocytic, endothelial and leucocyte vacuolation. LAMP-2 deficient mice represent a valuable animal model of Danon disease. They will further be used to study the exact role of LAMP-2 in autophagy and to analyse the consequences of an impaired autophagic pathway in various tissues.

UR - http://www.scopus.com/inward/record.url?scp=0034475043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034475043&partnerID=8YFLogxK

U2 - 10.1016/S1471-4914(00)01868-2

DO - 10.1016/S1471-4914(00)01868-2

M3 - Review article

C2 - 11427988

AN - SCOPUS:0034475043

VL - 7

SP - 37

EP - 39

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

SN - 1471-4914

IS - 1

ER -